Electronic health records (EHRs) may or may not be ready for prime time, but a new FDA draft guidance for the use of EHRs in conjunction with clinical trials states that a study sponsor is responsible for ensuring that updates to a clinic’s EHR system will have no impact on the data transmitted to the sponsor from the clinical study site.